The number of patients, summed across the months April to March, who have been waiting more than 3 months from decision to treat for either coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) divided by the total number of patients who have received CABG or PTCA for the financial year using the cumulative activity figures reported in the March (year end) Monthly Monitoring Return. The figure is expressed as a percentage.
Circulatory disease accounts for nearly 40% of all deaths among men and women in England every year and coronary heart disease (CHD) is one of the biggest killers. Many people are living with CHD: more than 1.4 million suffer with angina and 300,000 have heart attacks every year1. The effects of heart disease are not evenly distributed across different strata of society.The National Service Framework for Coronary Heart Disease1 states that there is good evidence that many people with atheromatous plaques and narrowed coronary arteries can have their symptoms relieved and/or their risks of dying reduced by restoring blood flow through block coronary arteries – revascularisation. In 1996 waiting times for procedures were more than 2 years in some places2 and a series of targets within Priorities and Planning Frameworks3,4 were introduced to reduce this wait.The ultimate government target was to deliver a maximum wait of three months for revascularisation by March 2005.
This indicator has been discontinued and so there will be no further updates.
Legacy unique identifier: P01057